Aldeyra Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

4 reportsHistory

—≥ implied

Aug 5 '22±19.4%▲+10.90%×0.56

Nov 10 '22—▲+6.18%—

Mar 9 '23±7.5%▲+7.19%×0.96

May 4 '23±13.6%▲+2.06%×0.15

quarterimplied−20%0+20%realized×

May '23±13.6%▲+2.06%×0.15

Mar '23±7.5%▲+7.19%×0.96

Nov '22—▲+6.18%—

Aug '22±19.4%▲+10.90%×0.56

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2

106managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+4.80%change in shares held by the ten largest reporting managers13F · Jun 30 '26

Bear2

19managers whose positions make up four fifths of reported value13F · Jun 30 '26

10 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

ALDX report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.